US Patent 7829096 CD40L-specific monovalent polypeptides
Patent 7829096 was granted and assigned to Domantis Limited on November, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 1, 2009
Date of Patent
November 9, 2010
Patent Application Number
12387421
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7829096 CD40L-specific monovalent polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.